Mass General Receives $50 Million for Tuberous Sclerosis Center

Mass General Receives $50 Million for Tuberous Sclerosis Center

Massachusetts General Hospital has announced a $50 million gift from Carol J. and James S. Herscot in support of capital projects, initiatives, and the Herscot Center for Children and Adults with Tuberous Sclerosis Complex (TSC).

Established with a $10 million gift from the couple in 2005, the Herscot Center works to improve the diagnosis and treatment of TSC. In addition to providing comprehensive clinical care to hundreds of patients annually, the center conducts and publishes clinical research aimed at advancing understanding of TSC and educating physicians around the world. In recognition of the couple's longtime support — which includes a $17.5 million gift in 2017 — the facility that houses the Herscot Center will be named the Carol and James Herscot Building. 

TSC is a rare genetic disorder that alters fundamental cellular signals and can affect every organ in the body. One of the most frequently affected organs is the brain, where TSC can cause seizures, autism, cognitive impairment, and mental health disorders. Because tumors grow throughout the body, causing a wide variety of symptoms, the disease is often misdiagnosed. Since their son Brad was diagnosed with TSC nearly fifty years ago, the Herscots have devoted themselves to helping other patients and families affected by the disease.

"Jim and Carol have been among the hospital's strongest supporters and champions for more than fifty years," said MGH president Peter L. Slavin. "Through founding the Herscot Center and providing vital support for other hospital-wide efforts, their vision, friendship, and generosity has been enormously helpful to advancing the MGH mission."